Covenant Health Oncology Group - Lenoir City

Lenoir City, Tennessee 37772

0 studies enrolling now · 5 studies all time

What they study most

Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Breast Carcinoma In Situ, COVID-19 Infection, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Colon Adenocarcinoma, DNA Repair Disorder, Hematopoietic and Lymphatic System Neoplasm, Invasive Breast Carcinoma, Lynch Syndrome, Malignant Solid Neoplasm, Metastatic Anal Squamous Cell Carcinoma

Studies at this site

• Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair — Running, not enrolling
• NCI COVID-19 in Cancer Patients, NCCAPS Study — Running, not enrolling
• EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients — Running, not enrolling
• Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer — Running, not enrolling
• Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers — Running, not enrolling